REXULTI

Details for Australian Trade Mark No. 1503037 (hide)

Classes

Class 5 Pharmaceutical preparations; pharmaceutical preparation and substances for the prevention and treatment of disorders and diseases in, generated from or affecting the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease, depression, psychosis, anxiety, epilepsy, sclerosis, porphyries, Huntington's disease, insomnia, Parkinson disease, schizophrenia, bipolar disorder, oncology, pain, alcoholism and dependency; preparations, substances, reagents and agents for diagnostic and medical purposes

Event Publications

26 July 2012 Application filed

9 August 2012 Application Accepted

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.